Wang, Zheng
Yan, Meisi
Ye, Leiguang
Zhou, Qimin https://orcid.org/0000-0002-9480-4872
Duan, Yuran
Jiang, Hongfei
Wang, Lei https://orcid.org/0000-0003-3556-5004
Ouyang, Yuan https://orcid.org/0000-0003-4889-1271
Zhang, Huahe
Shen, Yuli
Ji, Guimei
Chen, Xiaohan
Tian, Qi
Xiao, Liwei
Wu, Qingang https://orcid.org/0000-0002-6928-6268
Meng, Ying
Liu, Guijun
Ma, Leina
Lei, Bo https://orcid.org/0000-0002-5613-5233
Lu, Zhimin https://orcid.org/0000-0003-3819-7403
Xu, Daqian https://orcid.org/0000-0003-0478-2997
Funding for this research was provided by:
Ministry of Science and Technology of the People’s Republic of China (2021YFA0805600)
Ministry of Science and Technology of the People’s Republic of China (2020YFA0803300)
MOST | National Natural Science Foundation of China (82188102,82030074)
MOST | National Natural Science Foundation of China (82072630,92157113)
MOST | National Natural Science Foundation of China (82372814,82173114)
MOST | National Natural Science Foundation of China (82002811)
MOST | National Natural Science Foundation of China (82103658)
Shanghai pujiang program (2022PJD040)
黑龙江省科技厅 | Natural Science Foundation of Heilongjiang Province (LH2023H095)
the project of Beijing medical award foundation (YXJL-2021-0581-0484)
MOST | NSFC | NSFC-Zhejiang Joint Fund | 浙江省科学技术厅 | Natural Science Foundation of Zhejiang Province (LD22H160002)
MOST | NSFC | NSFC-Zhejiang Joint Fund | 浙江省科学技术厅 | Natural Science Foundation of Zhejiang Province (LD21H160003)
MOST | NSFC | NSFC-Zhejiang Joint Fund | 浙江省科学技术厅 | Natural Science Foundation of Zhejiang Province (LQ22H160023)
Article History
Received: 9 March 2023
Revised: 23 January 2024
Accepted: 24 January 2024
First Online: 15 February 2024
Disclosure and competing interests statement
: ZL owns shares in Signalway Biotechnology (Pearland, TX), which supplied rabbit antibodies that recognize Beclin1 P54 hydroxylation. ZL’s interest in this company had no bearing on its being chosen to supply these reagents. The remaining authors declare no competing interests.